Duluth, MN 的 前列腺癌 臨床試驗
7 項針對 前列腺癌 的研究正在 Duluth（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中觀察性研究歡迎健康志工
- Essentia Health Cancer Center, Duluth
- Essentia Health Saint Mary's Medical Center, Duluth
- Miller-Dwan Hospital, Duluth
- 還有 2 項
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
招募中2 期
- Essentia Health Cancer Center, Duluth
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
招募中2 期
- Essentia Health Cancer Center, Duluth
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
招募中3 期
- Essentia Health Cancer Center, Duluth
- Essentia Health Saint Mary's Medical Center, Duluth
- Miller-Dwan Hospital, Duluth
- 還有 2 項
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
招募中3 期
- Essentia Health Cancer Center, Duluth
- Essentia Health Saint Mary's Medical Center, Duluth
- Miller-Dwan Hospital, Duluth
- 還有 1 項
Integrated Cancer Repository for Cancer Research
招募中觀察性研究歡迎健康志工
- Essentia Health - Duluth Clinic, Duluth
- St. Luke's Hospital of Duluth, Duluth
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中觀察性研究
- Massive Bio SYNERGY-AI site, Duluth
其他城市的 前列腺癌 試驗
- New York City, NY103 項研究
- Houston, TX76 項研究
- Los Angeles, CA61 項研究
- Boston, MA59 項研究
- St. Louis, MO46 項研究
- Chicago, IL45 項研究
- San Francisco, CA45 項研究
- Philadelphia, PA44 項研究
- Baltimore, MD43 項研究
- Nashville, TN42 項研究
- Seattle, WA42 項研究
- Washington, DC38 項研究
Duluth 的其他研究
- 非小細胞肺癌13 項研究
- 肺癌11 項研究
- 乳癌7 項研究
- 結腸癌6 項研究
- 膀胱癌6 項研究
- 急性髓系白血病6 項研究
- 子宮內膜癌5 項研究
- 胃癌5 項研究
- 直腸癌5 項研究
- 食道癌5 項研究
- 喉癌5 項研究
- 黑色素瘤5 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月5日。各研究自行設定資格標準；由研究團隊決定參與者資格。